KYORIN Rimedio Co., Ltd.

Based in Japan, KYORIN Rimedio Co. , Ltd. , operates as a manufacturer and seller of pharmaceutical products, focusing on generic pharmaceuticals and over-the-counter health solutions. Founded in 1947, KYORIN Rimedio Co.

, Ltd. is based in Japan and specializes in the pharmaceutical sector. The company manufactures and sells a range of pharmaceutical products, including generic drugs and over-the-counter items. In September 2026, KYORIN Rimedio was fully acquired by DAITO Co.

, Ltd. , Meiji Seika Pharma, and the Development Bank of Japan, with the aim of consolidating operations and enhancing manufacturing capabilities. KYORIN Rimedio Co. , Ltd.

specializes in the manufacturing and sale of generic pharmaceuticals and over-the-counter (OTC) products. The company offers prescription pharmaceuticals for healthcare providers and daily health products for consumers, prioritizing patient welfare and safety in treatment options. Its products cater to healthcare professionals, patients, and families, focusing on the Japanese market and adhering to safety and regulatory standards. Revenue generation at KYORIN Rimedio occurs through B2B and B2C sales channels, engaging healthcare professionals and institutions as clients.

The company collaborates with pharmacies and healthcare facilities to distribute its prescription drugs and health products, ensuring access to consumers. The sales structure includes direct sales to healthcare providers and retail strategies for OTC offerings, emphasizing trust and quality within the Japanese healthcare system. The company plans to consolidate its generic pharmaceutical operations and strengthen its manufacturing capacity following its acquisition in September 2026. Current initiatives include improving quality management and enhancing supply chain resilience to ensure a stable drug supply.